DOI: 10.1001/jamaophthalmol.2023.2421 2023
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration Charles C. Wykoff, David M. Brown, Kimberly Reed, Alyson J. Berliner, Adam T. Gerstenblith, Aurora Breazna, Prema Abraham, Jordana G. Fein, Karen W. Chu, W. Lloyd Clark, Sergio Leal, Thomas Schmelter, Boaz Hirshberg, George D. Yancopoulos, Robert Vitti, Suhail Alam, Astrid Gonzalez Ramos, Daniel Virgil Alfaro, Sean Adrean, John Payne, Harold Brooks, Mark Chittum, David Callanan, Ralph Paylor, Clement Chan, John Allen, Nauman Chaudhry, Margaret Chang, Sanford Chen, William Bridges, James Dooner, Wayne Solley, Andres Emanuelli, Ronald Teed, Scott Friedman, Nader Moinfar, Ghassan Ghorayeb, Shelly Lee, Daniel Berinstein, Mitchell Goff, Harvey Reiser, Amir Guerami, Emily Ashmore, Curtis Hagedorn, Jose Martinez, Paul Hahn, Juner Colina-Biscotto, Vrinda Hershberger, Brian Joondeph, Erik Kruger, J. Shepard Bryan, Michael Lee, Mark Chiu, C. Nathaniel Roybal, Frank Wyant, James Luu, Matthew Byun, James Palmer, Mark Wieland, Joel Pearlman, Evan Berger, John Pitcher, Rajiv Rathod, Omar Punjabi, Leonard Feiner, Hema Ramkumar, Steven Lin, Rahul Reddy, Richard Dreyer, Nathan Steinle, Veeral Sheth, David Faber, Cameron Stone, Robert Engstrom, Robert Wirthlin, Mahmood El-Gasim, Robert Parnes,